Cite
HARVARD Citation
Cheng, Y. et al. (2022). Aiding early clinical drug development by elucidation of the relationship between tumor growth inhibition and survival in relapsed/refractory multiple myeloma patients. EJHaem. 3 (3), pp. 815-827. [Online].